Efficacy and safety of lenalidomide in diffuse large B-cell lymphoma: a meta-analysis of randomized controlled trials

医学 来那度胺 内科学 中性粒细胞减少症 危险系数 发热性中性粒细胞减少症 相对风险 不利影响 随机对照试验 弥漫性大B细胞淋巴瘤 肿瘤科 置信区间 胃肠病学 淋巴瘤 多发性骨髓瘤 化疗
作者
Jia Liu,Ruihua Mi,Lin Chen,Xiaoli Guo,Taotao Liang,Qingsong Yin
出处
期刊:Clinical and Experimental Medicine [Springer Science+Business Media]
卷期号:23 (4): 1161-1169 被引量:2
标识
DOI:10.1007/s10238-022-00920-2
摘要

As an immunomodulatory agent with antitumor activity, lenalidomide has been evaluated for its value in diffuse large B-cell lymphoma (DLBCL). We performed a meta-analysis to gain a better understanding of the efficacy and safety of lenalidomide in DLBCL. PubMed, Cochrane Library, and Embase were searched up to March 2022 for potential studies. The pooled hazard ratio (HR) and relative risk (RR) with 95% confidence interval (CI) were estimated by the fixed/random effects model. Overall, 6 randomized controlled trials including 1938 patients were included. The complete response rate (CRR) of the group containing lenalidomide was 47.7% (95%CI 28.5-67.2%), which was higher than the 37.8% (95%CI 16.7-61.5%) of the control group without lenalidomide (RR = 1.11, 95%CI 1.03-1.20, P = 0.008). The overall estimation of survival showed a benefit for progression-free survival (PFS) (HR = 0.77, 95%CI 0.66-0.90, P = 0.001) but not overall survival (OS) or event-free survival (EFS). The lenalidomide group had a significant incidence of grade ≥ 3 hematological adverse events (AEs) involving neutropenia (RR = 1.56, 95%CI 1.15-2.11, P = 0.004) and febrile neutropenia (RR = 1.81, 95%CI 1.31-2.49, P < 0.001), with the incidence of neutropenia (48.3%, 95%CI 37.5-59.1%) being highest. In conclusion, addition of lenalidomide results in a higher CRR and better PFS but a higher incidence of grade ≥ 3 hematological AEs involving neutropenia and febrile neutropenia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
每天都好饿完成签到,获得积分10
3秒前
4秒前
知更鸟完成签到,获得积分10
6秒前
HeJiangle完成签到,获得积分20
6秒前
7秒前
xmz发布了新的文献求助10
7秒前
丁可发布了新的文献求助10
8秒前
8秒前
9秒前
画月给画月的求助进行了留言
10秒前
Ava应助科研通管家采纳,获得10
10秒前
小蘑菇应助科研通管家采纳,获得20
10秒前
英俊的铭应助科研通管家采纳,获得10
10秒前
Hello应助科研通管家采纳,获得10
11秒前
彭于晏应助科研通管家采纳,获得10
11秒前
爆米花应助科研通管家采纳,获得10
11秒前
丘比特应助科研通管家采纳,获得10
11秒前
桐桐应助科研通管家采纳,获得10
11秒前
斯文败类应助科研通管家采纳,获得10
11秒前
dong应助科研通管家采纳,获得10
11秒前
今后应助科研通管家采纳,获得10
11秒前
量子星尘发布了新的文献求助10
12秒前
萧水白应助科研通管家采纳,获得10
12秒前
12秒前
任性的皮皮虾完成签到,获得积分10
14秒前
魏少爷发布了新的文献求助10
14秒前
14秒前
14秒前
14秒前
Jason发布了新的文献求助10
14秒前
15秒前
mmyhn应助kdjm688采纳,获得10
16秒前
希望天下0贩的0应助2jz采纳,获得10
17秒前
冷傲冬易完成签到,获得积分10
17秒前
M1982发布了新的文献求助10
19秒前
flippedaaa发布了新的文献求助10
20秒前
20秒前
xue发布了新的文献求助10
20秒前
潮汐发布了新的文献求助10
21秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
The Moiseyev Dance Company Tours America: "Wholesome" Comfort during a Cold War 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3980224
求助须知:如何正确求助?哪些是违规求助? 3524191
关于积分的说明 11220260
捐赠科研通 3261653
什么是DOI,文献DOI怎么找? 1800792
邀请新用户注册赠送积分活动 879296
科研通“疑难数据库(出版商)”最低求助积分说明 807232